AEON Biopharma Inc. - Ordinary Shares - Class A

ASE:AEON  
0.84
-0.02 (-2.33%)
6:27:01 PM EDT: $0.83 -0.01 (-0.62%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

AEON Biopharma Inc. - Ordinary Shares - Class A Stock, ASE:AEON

5 Park Plaza, Suite 1750, Irvine, California 92614
United States of America
Phone: +1.949.354.6499
Number of Employees: 10

Description

AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.